Final report of University Hospital Hradec Kralove to the clinical trial protocol no. SGN35-010

Abstract

Realization of a part of clinical trial called A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

Keywords

• Brentuximab
• Vedotin
• Hodgkin Lymphoma